C5AR2 and breast neoplasm: GPR77 and CD10 are potential targeted biomarkers as the infiltration of CD10+GPR77+ CAFs indicates chemotherapy resistance and poor survival, especially in the ER−HER2− subtype and high-grade breast tumors.